EX-32.1 6 curr_ex321.htm CERTIFICATION curr_ex321.htm

EXHIBIT 32.1

 

CURE PHARMACEUTICAL HOLDING CORP.

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with this Annual Report on Form 10-K of CURE Pharmaceutical Holding Corp. (the “Company”) for the year ended December 31, 2018 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, in the capacity and on the date indicated below, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to her knowledge:

 

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

 

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.

 

 

 

Date:

April 1, 2019

 

 

 

By:

/s/ Robert Davidson

 

Name:

Robert Davidson

 

Title:

Chief Executive Officer (Principal Executive Officer)